The Cancer SIGNAL GRAIL

Valerie kept active, felt healthy, and enjoyed spending time with her friends and family. Although she didn’t have symptoms, she took the Galleri test, which found a positive cancer signal. After additional evaluations, it was confirmed she had early-stage gallbladder cancer and was able to take action. Valerie shares her experience taking the test, what the results meant, her treatment journey and outlook for the future.

Step into the lab with Rita Shaknovich, vice president of medical affairs and head of clinical laboratories at GRAIL, as she dives into the science behind the Galleri test and brings to life the process that a Galleri test sample goes through from beginning to end. 

Many U.S. veterans may be at an increased risk of cancer, making access to early detection critical to their health. Dr. Charles Atwood, pulmonologist and lead researcher for the REFLECTION Study at the VA Pittsburgh Healthcare System, joins The Cancer SIGNAL to discuss the work being done to expand early cancer detection for veterans.

GRAIL’s founder, Dr. Rick Klausner and president, Joshua Ofman, join host Kim Thiboldeaux to discuss the science behind multi-cancer early detection, the technology being pioneered, and how the tests have the potential to help find cancer earlier in people with elevated risk.

Each month, Kim Thiboldeaux, former CEO and Executive Chair of the Cancer Support Community, will host a discussion around multi-cancer early detection, its origin and promise for anyone at high risk for cancer, the science behind the screening tests, and insight into how this technology has the potential to shift the cancer paradigm. Guests will include healthcare pioneers and providers, advocates, policymakers, and others who will share their perspectives and experiences with multi-cancer early detection testing. Subscribe to The Cancer SIGNAL to hear more.